Marc Lipsitch
Marc Lipsitch
Department of Epidemiology, Harvard School of Public Health
Verified email at - Homepage
Cited by
Cited by
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
SM Kissler, C Tedijanto, E Goldstein, YH Grad, M Lipsitch
Science 368 (6493), 860-868, 2020
BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting
N Dagan, N Barda, E Kepten, O Miron, S Perchik, MA Katz, MA Hernán, ...
New England Journal of Medicine 384 (15), 1412-1423, 2021
Transmission dynamics and control of severe acute respiratory syndrome
M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma, L James, ...
science 300 (5627), 1966-1970, 2003
Defining the epidemiology of Covid-19—studies needed
M Lipsitch, DL Swerdlow, L Finelli
New England journal of medicine 382 (13), 1194-1196, 2020
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
JT Wu, K Leung, M Bushman, N Kishore, R Niehus, PM de Salazar, ...
Nature medicine 26 (4), 506-510, 2020
Covid-19 breakthrough infections in vaccinated health care workers
M Bergwerk, T Gonen, Y Lustig, S Amit, M Lipsitch, C Cohen, ...
New England Journal of Medicine 385 (16), 1474-1484, 2021
How generation intervals shape the relationship between growth rates and reproductive numbers
J Wallinga, M Lipsitch
Proceedings of the Royal Society B: Biological Sciences 274 (1609), 599-604, 2007
Negative controls: a tool for detecting confounding and bias in observational studies
M Lipsitch, ET Tchetgen, T Cohen
Epidemiology 21 (3), 383-388, 2010
Serotype replacement in disease after pneumococcal vaccination
DM Weinberger, R Malley, M Lipsitch
The Lancet 378 (9807), 1962-1973, 2011
Transmissibility of 1918 pandemic influenza
CE Mills, JM Robins, M Lipsitch
Nature 432 (7019), 904-906, 2004
Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting
N Barda, N Dagan, Y Ben-Shlomo, E Kepten, J Waxman, R Ohana, ...
New England Journal of Medicine 385 (12), 1078-1090, 2021
Public health interventions and epidemic intensity during the 1918 influenza pandemic
RJ Hatchett, CE Mecher, M Lipsitch
Proceedings of the National Academy of Sciences 104 (18), 7582-7587, 2007
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
N Barda, N Dagan, C Cohen, MA Hernán, M Lipsitch, IS Kohane, BY Reis, ...
The Lancet 398 (10316), 2093-2100, 2021
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
R Malley, P Henneke, SC Morse, MJ Cieslewicz, M Lipsitch, ...
Proceedings of the National Academy of Sciences 100 (4), 1966-1971, 2003
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
KM Bubar, K Reinholt, SM Kissler, M Lipsitch, S Cobey, YH Grad, ...
Science 371 (6352), 916-921, 2021
Absolute humidity and the seasonal onset of influenza in the continental United States
J Shaman, VE Pitzer, C Viboud, BT Grenfell, M Lipsitch
PLoS biology 8 (2), e1000316, 2010
Antibiotics in agriculture and the risk to human health: how worried should we be?
Q Chang, W Wang, G Regev‐Yochay, M Lipsitch, WP Hanage
Evolutionary applications 8 (3), 240-247, 2015
Antimicrobial use and antimicrobial resistance: a population perspective
M Lipsitch, MH Samore
Emerging infectious diseases 8 (4), 347, 2002
Evaluating treatment protocols to prevent antibiotic resistance
S Bonhoeffer, M Lipsitch, BR Levin
Proceedings of the National Academy of Sciences 94 (22), 12106-12111, 1997
Interleukin-17A mediates acquired immunity to pneumococcal colonization
YJ Lu, J Gross, D Bogaert, A Finn, L Bagrade, Q Zhang, JK Kolls, ...
PLoS pathogens 4 (9), e1000159, 2008
The system can't perform the operation now. Try again later.
Articles 1–20